Germany’s BioNTech Settles With US Agency, UPenn Over COVID Vaccine Royalties
Insurance Journal - Dec 27, 2024
BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University of Pennsylvania over the payment of royalties related to its COVID-19 vaccine, the company said in filings. The German company, which partners …...
Recommended Articles
Posted: Nov 04, 2025
McCrosson Joins AXA XL Reinsurance as Senior Underwriter, US Property Treaty AXA XL Reinsurance hire...
Posted: Nov 04, 2025
CNA Financial Corp. recorded third quarter net income of $403 million compared with $283 million a y...
Posted: Nov 04, 2025
Armed assailants attacked a commercial tanker off the coast of Mogadishu on Monday, firing at the ve...